C Tikellis, PJ Wookey, R Candido, S … - Diabetes, 2004 - Am Diabetes Assoc The renin-angiotensin system (RAS) has an important role in the endocrine
pancreas. Although angiotensin II has significant effects on cell proliferation
and apoptosis, the contribution of the RAS to changes in islet structure ... Cited by 118 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org JR Kizer, B Dahlof, SE Kjeldsen, S Julius, G … - Hypertension, 2005 - Am Heart Assoc From the Weill Medical College of Cornell University (JRK, RBD), New York, NY;
Sahlgrenska/Östra University Hospital (BD), Gothenburg, Sweden; Ullevaal
University Hospital (SEK), Oslo, Norway; University of Michigan (SJ), Ann ... Cited by 67 - Related articles - All 9 versions
- ►sld.cu [PDF] JL Izzo, AH Gradman - Medical Clinics of North America, 2004 - Elsevier Hypertensive heart disease (HHD) is a spectrum of abnormalities that represents
the accumulation of a lifetime of functional and structural adaptations to
increased blood pressure (BP) load. Left ventricular hypertrophy (LVH), ... Cited by 35 - Related articles - All 6 versions
J Shao, N Iwashita, F Ikeda, T Ogihara, T … - Biochemical and biophysical research communications, 2006 - Elsevier Several epidemiological studies suggested that treatment with angiotensin II
type 1 receptor blocker (ARB) provided a risk reduction of developing type 2
diabetes. In this study, we investigated whether and how ARB treatment can ... Cited by 31 - Related articles - All 6 versions
- ►adisonline.com [PDF] PA Meredith - American Journal of Cardiovascular Drugs, 2005 - ingentaconnect.com Angiotensin II receptor antagonists (angiotensin receptor blockers; ARBs) and
thiazide diuretics have an Abstract accepted place in the management of
hypertension. Most patients require combination therapy with two or more ... Cited by 25 - Related articles - All 7 versions
- ►ahajournals.org F Fyhrquist, B Dahlof, RB Devereux, SE … - Hypertension, 2005 - Am Heart Assoc From Helsinki University Central Hospital (FF) and Minerva Institute for Medical
Research, Helsinki, Finland; Sahlgrenska University Hospital/Östra (BD),
Gothenburg, Sweden; Weill Medical College of Cornell University (RBD), New ... Cited by 18 - Related articles - All 8 versions
K Park, JW Shin, JK Oh, KS Ryu, SW Kim, JS … - Journal of andrology, 2005 - Am Soc Andrology We investigated the effects of systemic modulation of angiotensin 2 on the
erectile dysfunction of aged rats. Young and aged (18 months old) male
Sprague-Dawley rats were either treated with daily administration of ... Cited by 14 - Related articles - All 6 versions
- ►adisonline.com [PDF] MD Moen, AJ Wagstaff - Drugs, 2005 - ingentaconnect.com 0012-6667/05/0018-2657/$39.95/0 2005 Adis Data Information BV. All rights
reserved. ... A Review of its Use in Stroke Risk Reduction in Patients with
Hypertension and Left Ventricular Hypertrophy Cited by 17 - Related articles - BL Direct - All 7 versions
RB Devereux, B Dahlöf - Current Medical Research and Opinion®, 2007 - informahealthcare.com Introduction: The Losartan Intervention For Endpoint reduction in hypertension
(LIFE) study is the first, and, so far, the only endpoint trial in patients with
hypertension and left ventricular hypertrophy (LVH) to show a divergent ... Cited by 12 - Related articles - BL Direct - All 5 versions
N Perico, P Ruggenenti, G Remuzzi - Expert Review of Cardiovascular Therapy, 2004 - ingentaconnect.com Diabetic nephropathy has become the single most important cause of end-stage
renal disease in the USA, Europe and Japan. The earliest marker of incipient
diabetic nephropathy is the transition of normoalbuminuria to ... Cited by 10 - Related articles - All 4 versions
